Publications
Publications
The academic record. Every entry carries a resolvable identifier and ties back to the ORCID record that gathers this name's work in one place.
One author, several spellings
Work by this author appears in the literature under more than one spelling. Dr. Yousef Binamer is the form bound to the ORCID record below, which is what ties them together.
- Yousef Binamer
- Yousef Bin Amer
- Yousef BinAmer
- يوسف بن عامر
- يوسف العامر
The record
A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study
Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis"
Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison
The Atopic Dermatitis Shared Decision-Making Tool: Implementing the AHEAD Approach in Clinical Practice
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)
Demographics, Clinical Characteristics, and Treatment Patterns in Patients with Psoriasis: Insights from the Saudi Arabia Psoriasis Registry (PSORSA)
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis
Impact of Simultaneous Itch Relief and Substantial Skin Clearance With Lebrikizumab in Patients With Atopic Dermatitis: Post-hoc Analysis From ADvocate1/2
Implementation of a specialty pharmacy in an ambulatory care setting in Saudi Arabia: Patient experience and operational outcomes
L’upadacitinib augmente la proportion de patients atteints de dermatite atopique modérée à sévère atteignant l’activité minimale de la maladie : résultats des études de phase 3 (measure up 1 et measure up 2)
Prevalence of Hidradenitis Suppurativa in Saudi Arabia
Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies
Real-world outcomes of dupilumab therapy in moderate-to-severe atopic dermatitis patients: an observational retrospective study in Gulf countries
Review on recommendations on the use of biologic therapy for the management of moderate-severe psoriasis in Saudi Arabia: an expert opinion
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis
Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia
L’upadacitinib augmente la proportion de patients atteints de dermatite atopique modérée à sévère atteignant l’activité minimale de la maladie : résultats des études de phase 3 (Measure Up 1 et Measure Up 2)
Patient-reported burden in adults with atopic dermatitis: an international qualitative study
Treatment With Upadacitinib Increases the Achievement of Minimal Disease Activity Among Patients With Moderate-to-Severe Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1 and Measure Up 2)
Achievement of minimal disease activity is associated with improvements in symptoms, quality of life and treatment satisfaction in patients with atopic dermatitis
Certolizumab to treat hidradenitis suppurativa
Effect of Atopic Dermatitis on Quality of Life and Healthcare Resource Utilization in Saudi Arabia
Gain-of-function variants in the KDF1 gene cause hidradenitis suppurativa associated with ectodermal dysplasia by stabilizing IκB kinase α
Kindler's Syndrome with Recurrent Neutropenia: Report of Two Cases from Saudi Arabia
Optimizing the management of atopic dermatitis with a new minimal disease activity concept and criteria and consensus-based recommendations for systemic therapy
Understanding the impact of atopic dermatitis on patients: a large international, ethnically diverse survey-based qualitative study
Management of Atopic Dermatitis in Adults in Saudi Arabia: Consensus Recommendations from the Dermatological Expert Group
National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021)
Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020)
The impact of social media on dermatologists and in captivating their patients: a cross-sectional study
PLACK syndrome is potentially treatable with intralipids
BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA
Giant extramucosal verruciform xanthoma over a discoid lupus erythematosus plaque in a patient with systemic lupus erythematosus
D-penicillamine-induced pseudo-pseudoxanthoma elasticum and extensive elastosis perforans serpiginosa with excellent response to acitretin
Homozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome
Rituximab/IVIG in pemphigus - a 10-year study with a long follow-up
Nonmelanoma skin cancer in Saudi Arabia: single center experience
PUVA - Induced Skin Cancer in Dark - Skin Patient : A Case Report
Topical Corticosteroid Induced Skin Limited Kaposi Sarcoma : Case Report and Literature Review
Cutaneous T-cell lymphoma in Saudi Arabia: retrospective single-center review
Exome sequencing identifies novel NTRK1 mutations in patients with HSAN-IV phenotype
Hidradenitis Suppurativa in Down Syndrome: A Case Series
KDF1, encoding keratinocyte differentiation factor 1, is mutated in a multigenerational family with ectodermal dysplasia
Xeroderma pigmentosum at a tertiary care center in Saudi Arabia
Novel mutations in TGM1 and ABCA12 cause autosomal recessive congenital ichthyosis in five Saudi families
Acute hemorrhagic edema of infancy after MMR vaccine
Gorlin Syndrome in a type IV-skin person with a novel PTCH1 mutation: Case report and literature review
Ichthyin (NIPAL4)-autosomal recessive congenital ichthyosis with atopic diathesis: Case report and literature review
Dermacase. Can you identify this condition? Drug-induced leukocytoclastic vasculitis
Dermacase. Can you identify this condition? Kerion (inflammatory tinea capitis)
Treatment of ulcerative necrobiosis lipoidica with topical calcineurin inhibitor: case report and literature review
CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis
Importance of CD109 and Transforming Growth Factor-β Signaling in Psoriasis
Interferon-induced vitiligo in hepatitis C patients: a case series
Rapidly growing nodule on the finger of a pregnant woman
Squamous cell carcinoma of the lip after allogeneic hemopoietic stem cell transplantation
Fatal malignant melanoma in a child with neurofibromatosis type 1
For appointments and coordination only. Do not send medical details or clinical photographs.
Contact the coordinator on WhatsApp